Publication:
Pars Plana Vitrectomy for Ocular Complications of Behçet's Disease

dc.authorscopusid6602733678
dc.authorscopusid8718042600
dc.authorscopusid8540670800
dc.authorscopusid7005906397
dc.contributor.authorSüllü, Y.
dc.contributor.authorAlotaiby, H.
dc.contributor.authorBeden, U.
dc.contributor.authorErkan, D.
dc.date.accessioned2020-06-21T15:36:47Z
dc.date.available2020-06-21T15:36:47Z
dc.date.issued2005
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Süllü] Ýüksel, Department of Ophthalmology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Alotaiby] Hesham, Department of Ophthalmology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Beden] Ümit, Department of Ophthalmology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Erkan] Dilek, Department of Ophthalmology, Ondokuz Mayis Üniversitesi, Samsun, Turkeyen_US
dc.description.abstractBACKGROUND AND OBJECTIVES: To evaluate the outcomes of vitreoretinal surgery for the ocular complications of Behçet's disease. PATIENTS AND METHODS: This retrospective study included 20 eyes of 15 patients with Behçet's disease (9 men, 6 women; mean age at surgery, 31.0 ± 1.8 years; range, 21-44 years) who had undergone vitreoretinal surgery for Behçet's disease at Ondokuz Mayis University, Faculty of Medicine, Department of Ophthalmology, Samsun, Turkey, between January 2000 and September 2003. Postoperative visual acuity outcome, course of uveitis, and complications were evaluated in all patients. RESULTS: Indications for surgery were vitreous opacities in 10 eyes (50%), cystoid macular edema in 5 eyes (25%), epiretinal membrane in 3 eyes (15%), and vitreous hemorrhage in 2 eyes (10%). At the last postoperative follow-up, visual acuity had increased 2 Snellen lines or more in 10 (50%) of 20 eyes. Cystoid macular edema completely improved in 3 (60%) of 5 eyes after vitrectomy. Uveitis attacks significantly decreased during follow-up (P = .015). Immunosuppressive treatment was stopped in 11 (73%) of 15 patients. Retinal detachment and phthisis were not observed in any eye. CONCLUSION: Vitreoretinal surgery may be useful in the treatment of posterior segment complications of Behçet's disease.en_US
dc.identifier.doi10.3928/1542-8877-20050701-07
dc.identifier.endpage297en_US
dc.identifier.issn1542-8877
dc.identifier.issn1938-2375
dc.identifier.issue4en_US
dc.identifier.pmid16156145.0
dc.identifier.scopus2-s2.0-23044464119
dc.identifier.scopusqualityN/A
dc.identifier.startpage292en_US
dc.identifier.urihttps://doi.org/10.3928/1542-8877-20050701-07
dc.identifier.volume36en_US
dc.identifier.wosWOS:000232140900005
dc.identifier.wosqualityN/A
dc.language.isoenen_US
dc.publisherSlack Incorporateden_US
dc.relation.ispartofOphthalmic Surgery Lasers and Imagingen_US
dc.relation.journalOphthalmic Surgery Lasers & Imagingen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titlePars Plana Vitrectomy for Ocular Complications of Behçet's Diseaseen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files